Research and Markets: Dyslipidemia Therapeutics - Global Strategic Business Report - US$ Million by the Following Segments - Statins, and Non-Statins.

Business WireMay 20, 2010

Linked as:

Extract


Research and Markets: Dyslipidemia Therapeutics - Global Strategic Business Report - US$ Million by the Following Segments - Statins, and Non-Statins.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/23974f/dyslipidemia_thera) h...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company